VaxInnate Updates Plans to Advance Lead Vaccine Candidate, VAX2012Q in Elderly
08. Oktober 2014 09:00 ET
|
VaxInnate Corporation
Cranbury, NJ, Oct. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology platform, provided an update on
clinical development plans for...